Characteristics derived from outbreaks of pandemic influenza a (H1N1) 2009 virus

Clinical Infectious Diseases

Volumn 50, Issue 4, 2010, Pages 622-623

  Liu, Wei ^a   Tang, Fang ^b   Li, Zeng De ^b   Yang, Hong ^a   Cao, Wu Chun ^a  

^a Center for Diseases Control and Prevention of Chinese People's Armed Police Forces   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CLINICAL FEATURE; COMORBIDITY; DISEASE DURATION; EXPOSURE; FEVER; HUMAN; INCUBATION TIME; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LETTER; NUCLEOTIDE SEQUENCE; PANDEMIC; PRIORITY JOURNAL;

DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN;

EID: 75749118264     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/650179     Document Type: Letter

References (6)

1. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360(25): 2605-2615.
2. Ministry of Health of the People's Republic of China. Information on prevention and control of novel influenza A (H1N1) virus [in Chinese]. 27 June 2009. http://61.49.18.65/publicfiles/business/htmlfiles/mohbgt/s3582/200907/419 41.htm. Accessed 7 January 2010.
3. World Health Organization (WHO). Global Alert and Response (GAR). CDC protocol of realtime RTPCR for swine influenza A(H1N1). 6 October 2009 (originally published on 30 April 2009). http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/index.html. Accessed 7 January 2010.
4. Kamigaki T, Oshitani H. Lancet conferences: influenza in the Asia-Pacific. Expert Rev Vaccines 2009; 8(11):1527-1529.
5. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58(19):521-524.
6. Steel J, Staeheli P, Mubareka S, García-Sastre A, Palese P, Lowen AC. Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol 2009;84(1):21-26.